Stock Market News

EyePoint reports positive EYP-1901 trial results for wet AMD

2024.02.04 10:10


© Reuters.

WATERTOWN, Mass. – EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:) has introduced new subgroup analyses from its Phase 2 DAVIO 2 medical trial, which spotlight the potential of EYP-1901 as a therapy for wet age-related macular degeneration (wet AMD (NASDAQ:)). The information, introduced on the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting on Sunday, recommend EYP-1901 may alter the therapy paradigm for sufferers with this retinal illness.

EYP-1901 combines vorolanib, a tyrosine kinase inhibitor, with the bioerodible Durasert E expertise for sustained supply. The subgroup evaluation confirmed numerical superiority in visible acuity and anatomic stability for sufferers handled with EYP-1901 in comparison with these given aflibercept, with out the necessity for supplemental injections as much as six months.

The Phase 2 DAVIO 2 trial met its major endpoint, with EYP-1901 demonstrating statistical non-inferiority in visible acuity modifications and a positive security profile in comparison with aflibercept. Secondary endpoints have been additionally achieved, notably a major discount in therapy burden and powerful anatomical management.

EyePoint CEO Jay Duker, M.D., expressed confidence within the information, affirming that the positive outcomes have been attributable to EYP-1901. The firm plans to provoke Phase 3 trials within the second half of 2024, following discussions with the U.S. Food and Drug Administration (FDA).

Wet AMD is a number one reason for imaginative and prescient loss in people over 60, and present therapies require frequent injections. EYP-1901’s sustained supply may scale back this burden, with the current trial exhibiting as much as 88% therapy burden discount at six months.

EyePoint Pharmaceuticals can be progressing with different medical milestones for EYP-1901, together with a Phase 2 trial in non-proliferative diabetic retinopathy, with topline information anticipated within the second quarter of 2024.

This report relies on a press launch assertion from EyePoint Pharmaceuticals. The firm is devoted to the event and commercialization of therapeutics for severe retinal illnesses. Its pipeline options the proprietary Durasert E expertise for intraocular drug supply. EyePoint’s lead product candidate, EYP-1901, is below investigation for a number of VEGF-mediated retinal illnesses.

This article was generated with the help of AI and reviewed by an editor. For extra data see our T&C.

Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 51,008.67 1.29%
ethereum
Ethereum (ETH) $ 2,940.37 2.12%
tether
Tether (USDT) $ 0.999293 0.46%
bnb
BNB (BNB) $ 376.08 2.35%
solana
Solana (SOL) $ 101.15 3.00%
xrp
XRP (XRP) $ 0.538508 2.32%
staked-ether
Lido Staked Ether (STETH) $ 2,938.64 2.07%
usd-coin
USDC (USDC) $ 0.999377 0.13%
cardano
Cardano (ADA) $ 0.589741 1.23%
avalanche-2
Avalanche (AVAX) $ 36.32 3.08%
dogecoin
Dogecoin (DOGE) $ 0.084996 0.16%
tron
TRON (TRX) $ 0.138432 0.86%
chainlink
Chainlink (LINK) $ 18.12 2.30%
polkadot
Polkadot (DOT) $ 7.59 0.54%
matic-network
Polygon (MATIC) $ 0.994479 0.95%
uniswap
Uniswap (UNI) $ 10.99 46.29%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 50,981.66 1.64%
the-open-network
Toncoin (TON) $ 2.11 1.57%
internet-computer
Internet Computer (ICP) $ 12.46 4.17%
shiba-inu
Shiba Inu (SHIB) $ 0.00001 1.28%
bitcoin-cash
Bitcoin Cash (BCH) $ 265.04 0.55%
litecoin
Litecoin (LTC) $ 68.68 0.64%
dai
Dai (DAI) $ 0.998962 0.50%
immutable-x
Immutable (IMX) $ 3.08 7.23%
filecoin
Filecoin (FIL) $ 8.11 3.05%
cosmos
Cosmos Hub (ATOM) $ 9.99 0.35%
leo-token
LEO Token (LEO) $ 4.12 0.59%
kaspa
Kaspa (KAS) $ 0.16332 4.62%
bittensor
Bittensor (TAO) $ 588.03 2.50%
hedera-hashgraph
Hedera (HBAR) $ 0.109362 6.33%
ethereum-classic
Ethereum Classic (ETC) $ 25.60 1.86%
blockstack
Stacks (STX) $ 2.47 4.64%
near
NEAR Protocol (NEAR) $ 3.37 2.06%
optimism
Optimism (OP) $ 3.56 3.43%
aptos
Aptos (APT) $ 9.15 2.71%
first-digital-usd
First Digital USD (FDUSD) $ 0.999718 0.41%
stellar
Stellar (XLM) $ 0.115521 0.64%
vechain
VeChain (VET) $ 0.044165 2.95%
okb
OKB (OKB) $ 50.71 1.04%
injective-protocol
Injective (INJ) $ 33.39 4.53%
render-token
Render (RNDR) $ 7.46 3.62%
lido-dao
Lido DAO (LDO) $ 3.15 3.97%
celestia
Celestia (TIA) $ 16.42 4.47%
the-graph
The Graph (GRT) $ 0.271526 3.73%
mantle
Mantle (MNT) $ 0.791109 1.29%
crypto-com-chain
Cronos (CRO) $ 0.092109 1.57%
arbitrum
Arbitrum (ARB) $ 1.79 3.25%
monero
Monero (XMR) $ 122.42 0.83%
sei-network
Sei (SEI) $ 0.793248 7.92%
sui
Sui (SUI) $ 1.62 8.47%